Evidence map›Paper›PMID 34449724›Full record

ReviewPharmacy (Basel, Switzerland)2021

Clinical Pharmacy in Psychiatry: Towards Promoting Clinical Expertise in Psychopharmacology.

Hervé Javelot, Clara Gitahy Falcao Faria, Frederik Vandenberghe, Sophie Dizet, Bastien Langrée, Mathilde Le Maout, Céline Straczek, Adeline Egron, Alexis Erb, Guillaume Sujol and 5 more

Open access · goldAbstract readReview
In one paragraph

Review in Pharmacy (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Pharmacist-Led Education in Psychiatry Residency Training.Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry · 2024
    Article
  5. Article
  6. Article
  7. Attention Deficit Hyperactivity Disorder: What Are Pharmacists' Roles and Associated Outcomes?International journal of environmental research and public health · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 4 countries.

Hervé JavelotEtablissement Public de Santé Alsace Nord, 67170 Brumath, France.ORCID 0000-0002-2682-7677
Clara Gitahy Falcao FariaInstitute of Psychiatry, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 20211, Brazil.ORCID 0000-0002-1290-2349
Frederik VandenbergheUnit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neurosciences, Lausanne University Hospital, University of Lausanne, 1008 Prilly-Lausanne, Switzerland.ORCID 0000-0002-8964-2047
Sophie DizetCentre de Ressources et d'Expertise en Psychopharmacologie (CREPP) Bourgogne Franche-Comté, 71100 Chalon sur Saône, France.
Bastien LangréeService Pharmacie, Centre Hospitalier Guillaume Régnier, 35700 Rennes, France.ORCID 0000-0002-5490-3411
Mathilde Le MaoutDépartement de Pharmacie, CHU Henri Mondor, Université Paris Est Créteil (UPEC), AP-HP, 94000 Créteil, France.ORCID 0000-0002-4052-7654
Céline StraczekDépartement de Pharmacie, CHU Henri Mondor, Université Paris Est Créteil (UPEC), AP-HP, 94000 Créteil, France.
Adeline EgronService Pharmacie, Centre Hospitalier de Cadillac, 33410 Cadillac, France.
Alexis ErbAPF2R, Rouffach Centre Hospitalier, Pôle 8/9, 68250 Rouffach, France.
Guillaume SujolService Pharmacie, Centre Hospitalier Léon Jean Grégory, 66301 Thuir, France.ORCID 0000-0001-8057-1169
Antoine YrondiService de Psychiatrie et de Psychologie Médicale, CHU de Toulouse, Hôpital Purpan, 31059 Toulouse, France.
Sébastien WeibelService de Psychiatrie 2, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.ORCID 0000-0003-3887-3053
Philippe D VincentDepartment of Pharmacy, Institut Universitaire en Santé Mentale de Montréal (IUSMM), 7401 Hochelaga, Montreal, QC H1N 3M5, Canada.
Guillaume MeyerEtablissement Public de Santé Alsace Nord, 67170 Brumath, France.
Coraline HingrayPôle Hospitalo-Universitaire de Psychiatrie d'Adultes du Grand Nancy, Centre Psychothérapique de Nancy, 54520 Laxou, France.ORCID 0000-0002-7665-3310
Inserm · FRObservatoire Régional de la Santé d’Alsace · FRCentre hospitalier de Rouffach · FRCentre Hospitalier Guillaume Régnier · FRCentre Hospitalier Régional et Universitaire de Nancy · FRUniversidade Federal do Rio de Janeiro · BRUniversité de Montréal · CAUniversité Paris-Est Créteil · FRUniversité Toulouse III - Paul Sabatier · FRUniversity of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although clinical pharmacy is a discipline that emerged in the 1960s, the question of precisely how pharmacists can play a role in therapeutic optimization remains unanswered. In the field of mental health, psychiatric pharmacists are increasingly involved in medication reconciliation and therapeutic patient education (or psychoeducation) to improve medication management and enhance medication adherence, respectively. However, psychiatric pharmacists must now assume a growing role in team-based models of care and engage in shared expertise in psychopharmacology in order to truly invest in therapeutic optimization of psychotropics. The increased skills in psychopharmacology and expertise in psychotherapeutic drug monitoring can contribute to future strengthening of the partnership between psychiatrists and psychiatric pharmacists. We propose a narrative review of the literature in order to show the relevance of a clinical pharmacist specializing in psychiatry. With this in mind, herein we will address: (i) briefly, the areas considered the basis of the deployment of clinical pharmacy in mental health, with medication reconciliation, therapeutic education of the patient, as well as the growing involvement of clinical pharmacists in the multidisciplinary reflection on pharmacotherapeutic decisions; (ii) in more depth, we present data concerning the use of therapeutic drug monitoring and shared expertise in psychopharmacology between psychiatric pharmacists and psychiatrists. These last two points are currently in full development in France through the deployment of Resource and Expertise Centers in PsychoPharmacology (CREPP in French).

Indexed as

clinical pharmacyexpertisemental healthpsychiatrypsychopharmacology

Identifiers

PMID34449724
PMCPMC8396352
OpenAlexW3193748735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.